Matthew Christopher
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 8
- Acute Myeloid Leukemia Research 4
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 4
- Immunology top 2%
- Immune Response and Inflammation 6
- Immunotherapy and Immune Responses 3
- Oncology top 5%
- Chemokine receptors and signaling 6
- Bone health and treatments 3
- Emergency Medicine top 5%
- Hematological disorders and diagnostics 3
- Co-authors
- Daniel C. LinkYen‐Michael S. HsuLaura G. SchuettpelzAdam GreenbaumJoshua N. BorgerdingRyan B. DayTakashi NagasawaFulu Liu
- Cited by
- HematologyGeneticsImmunology
- Journals
- Blood (11 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesJapanAustralia
In The Last Decade
Matthew Christopher
24 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Hematology 1.2k
- Genetics 549
- Immunology 957
- Oncology 537
- Emergency Medicine 115
Countries citing papers authored by Matthew Christopher
This map shows the geographic impact of Matthew Christopher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Christopher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Christopher more than expected).
Fields of papers citing papers by Matthew Christopher
This network shows the impact of papers produced by Matthew Christopher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Christopher. The network helps show where Matthew Christopher may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthew Christopher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 21 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 6 | |
| 8 | 2020 | 11 | |
| 9 | 2020 | 34 | |
| 10 | 2019 | 11 | |
| 11 | 2019 | 15 | |
| 12 | CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenancebreakdown → | 2013 | 1026 |
| 13 | 2012 | 1 | |
| 14 | 2011 | 243 | |
| 15 | 2009 | 172 | |
| 16 | 2009 | 3 | |
| 17 | 2008 | 97 | |
| 18 | 2007 | 153 | |
| 19 | 2006 | 2 | |
| 20 | 2004 | 1 |
About Matthew Christopher
Matthew Christopher is a scholar working on Hematology, Oncology and Genetics, having authored 24 papers that have together received 2.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (8 papers), Chemokine receptors and signaling (6 papers), Immune Response and Inflammation (6 papers), Acute Myeloid Leukemia Research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Bone health and treatments (3 papers), Immunotherapy and Immune Responses (3 papers) and Hematological disorders and diagnostics (3 papers). The work is most often cited by research in Hematology (1.2k citations), Genetics (549 citations) and Immunology (957 citations). Matthew Christopher has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Daniel C. Link, Yen‐Michael S. Hsu, Laura G. Schuettpelz, Adam Greenbaum, Joshua N. Borgerding, Ryan B. Day, Takashi Nagasawa, Fulu Liu, Mahil Rao and Jill Woloszynek. Their work appears in journals such as Blood, Bioorganic & Medicinal Chemistry Letters, ACS Medicinal Chemistry Letters, Journal of Clinical Oncology and Current Opinion in Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.